Cargando…

Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection

BACKGROUND: Acute ischemic stroke secondary to aortic dissection (AoD) is challenging in the era of thrombolysis owing to the diagnostic difficulty within a narrow time window and the high risk of complications. CASE REPORT: A 64-year-old woman with middle cerebral artery occlusion syndrome admitted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Keun-Sik, Park, So-Young, Whang, Seon-Il, Seo, So-Young, Lee, Dong-Ha, Kim, Han-Joon, Cho, Joong-Yang, Cho, Yong-Jin, Jang, Woo-Ik, Kim, Chang Young
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686889/ https://www.ncbi.nlm.nih.gov/pubmed/19513335 http://dx.doi.org/10.3988/jcn.2009.5.1.49

Ejemplares similares

Delayed Surgery for Aortic Dissection after Intravenous Thrombolysis in Acute Ischemic Stroke
por: Choi, Nari, et al.
Publicado: (2016)

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015)

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients over 80 Years Old: The Fukuoka Stroke Registry
por: Matsuo, Ryu, et al.
Publicado: (2014)

Clinical Implications of Serial Glucose Measurements in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis
por: Kim, Joon-Tae, et al.
Publicado: (2018)

Clinical Results of the Intra-Arterial Thrombolysis with Stent Retriever Device Weather Perfusion Diffusion Mismatching and Intravenous Tissue Plasminogen Activator Administration
por: Kim, Young-Jin, et al.
Publicado: (2017)

Life-Threatening Anaphylactoid Reaction in an Acute Ischemic Stroke Patient With Intravenous rt-PA Thrombolysis, Followed by Successful Intra-Arterial Thrombolysis
por: Park, In-Serk, et al.
Publicado: (2008)

Prediction of Early Recanalization after Intravenous Thrombolysis in Patients with Large-Vessel Occlusion
por: Kim, Young Dae, et al.
Publicado: (2021)

Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
por: Nam, Ki-Woong, et al.
Publicado: (2017)

Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator
por: Liu, Shi-Ying, et al.
Publicado: (2018)

Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke
por: Choi, Jay Chol, et al.
Publicado: (2015)

Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator: Erratum
Publicado: (2019)

Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: Feasibility and effectivity from an Indian perspective
por: Sharma, S. R., et al.
Publicado: (2008)

Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis
por: Yang, Hung-Wei, et al.
Publicado: (2012)

Emergent Double-barrel Bypass Shortly after Intravenous Administration of Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
por: Choi, Joon-Ho, et al.
Publicado: (2016)

Abdominal wall hemorrhage after intravenous thrombolysis for acute ischemic stroke
por: An, Se-A, et al.
Publicado: (2013)

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2016)

Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
por: Doepp, Florian, et al.
Publicado: (2005)

Relationship between homocysteine level and prognosis of elderly patients with acute ischemic stroke treated by thrombolysis with recombinant tissue plasminogen activator
por: Li, Juan, et al.
Publicado: (2019)

High glycemic albumin representing prestroke glycemic variability is associated with hemorrhagic transformation in patients receiving intravenous thrombolysis
por: Lee, Sang-Hwa, et al.
Publicado: (2022)

Intravenous Thrombolysis in Ischemic Stroke Patients With Active Cancer
por: Selvik, Henriette Aurora, et al.
Publicado: (2018)

Remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke
por: He, Yao‐De, et al.
Publicado: (2020)

Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study
por: Zengin, Emine, et al.
Publicado: (2021)

Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous Thrombolysis
por: Choi, Jay Chol, et al.
Publicado: (2016)

Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society
por: TOYODA, Kazunori, et al.
Publicado: (2019)

Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)
por: Liu, Yunzhu, et al.
Publicado: (2022)

Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke
por: Hasumi, Keiji, et al.
Publicado: (2021)

Golden Hour Thrombolysis in Acute Ischemic Stroke: The Changing Pattern in South Korea
por: Kim, Hyunsoo, et al.
Publicado: (2021)

Various Blood Glucose Parameters that Indicate Hyperglycemia after Intravenous Thrombolysis in Acute Ischemic Stroke Could Predict Worse Outcome
por: Yoo, Deok-Sang, et al.
Publicado: (2014)

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
por: Cho, Hee Young, et al.
Publicado: (2021)

Negative Fluid-Attenuated Inversion Recovery-Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time
por: Aoki, Junya, et al.
Publicado: (2013)

Design of a standard Iranian protocol of Intravenous thrombolysis with tissue plasminogen activator: A national project
por: Ghandehari, Kavian
Publicado: (2013)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)

Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?
por: Almasi, Mostafa, et al.
Publicado: (2016)

Carotid Artery Stenting for Acute Ischemic Stroke Patients after Intravenous Recombinant Tissue Plasminogen Activator Treatment
por: Deguchi, Ichiro, et al.
Publicado: (2016)

Age-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke
por: Joo, Heesoo, et al.
Publicado: (2017)

Intravenous Thrombolysis for Acute Ischemic Stroke: Review of 97 Patients
por: Mehta, Anish, et al.
Publicado: (2017)

Chinese neurologists’ perspective on intravenous thrombolysis for acute ischemic stroke
por: Wang, Meng‐Die, et al.
Publicado: (2017)

Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate
por: Ragoschke-Schumm, Andreas, et al.
Publicado: (2017)

Cerebral autoregulation and response to intravenous thrombolysis for acute ischemic stroke
por: Nogueira, Ricardo C., et al.
Publicado: (2020)

Intravenous Thrombolysis for Acute Ischemic Stroke Due to Cardiac Myxoma
por: Esmaeili, Sara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m4ki2veg44j9vm0fvmb195r2go